AI model for predicting blood transfusions in ICU patients
This study uses artificial intelligence to create a model that predicts which ICU patients might need blood transfusions. By participating, you help improve transfusion decisions for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must be currently in the intensive care unit (ICU).
- Your complete medical records, including lab tests and transfusion data, must be available.
- This must be your first ICU admission during this hospital stay (repeat admissions are excluded).
- You must provide consent for your data to be used in research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if giving doctors artificial intelligence (AI) tools at the bedside helps them make better decisions for critically ill patients in the intensive care unit (ICU). If you are an adult admitted to the medical ICU, you may be eligible.
This study compares two blood test methods to help predict sepsis (a severe infection) and patient outcomes in the intensive care unit. It may help doctors identify high-risk patients faster and more accurately.
This study measures a specific blood protein (carbohydrate-deficient transferrin) when patients arrive at the hospital to see if it can predict how well they'll do in the intensive care unit. Understanding this marker might help doctors better plan care for critically ill patients.
This study is looking at whether certain blood tests can help predict the risk of death after surgery in ICU patients. If you have had surgery and are now in the ICU, your blood samples may help doctors learn more.
This study uses an artificial intelligence system to analyze electronic health records and predict which hospital patients might develop an infection. If you join, your health data will be used to train the AI, which could help prevent infections in the future.
This study looks for early markers in the blood that can predict a serious lung reaction called TRALI after a blood transfusion in ICU patients. It compares blood samples from different groups to find these markers, which could help prevent future reactions.
Hear when a new Critical Illness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.